AbbVie Inc. (ABBV) is listed on NYSE in Pharmaceutical Stocks. It is $255.53, -1.01%, with a $451.6B market cap. RSI is 48.7, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 48.7 Neutral
Market Cap $451.6B
Volume 2.1M
Fundamentals — 10-Q Q2 2026
Revenue $32.0B
Net Income $4.3B
EPS $2.42
Gross Margin 73.4%
Operating Margin 32.6%
Net Margin 13.5%
P/E Ratio 105.6x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 32,710 | $250.00 | $8.2M | 2026 Aug 14 |
| Purdue David Ryan | SVP, Controller | Sell | 5,230 | $233.56 | $1.2M | 2026 Mar 4 |
| Siatis Perry C | EVP, GC AND SECRETARY | Sell | 18,668 | $234.39 | $4.4M | 2026 Mar 2 |
| Siatis Perry C | EVP, GC AND SECRETARY | Sell | 22,381 | $230.00 | $5.1M | 2026 Feb 25 |
| Saleki-Gerhardt Azita | EVP, CHIEF OPERATIONS OFFICER | Sell | 42,370 | $198.42 | $8.4M | 2025 Aug 12 |
| Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 13,295 | $198.51 | $2.6M | 2025 Aug 5 |
| Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Sell | 58,832 | $210.08 | $12.4M | 2025 Mar 31 |
| Reents Scott T | EVP, CHIEF FINANCIAL OFFICER | Sell | 17,644 | $212.34 | $3.7M | 2025 Mar 14 |
| Gonzalez Richard A | Director | Sell | 98,628 | $205.45 | $20.3M | 2025 Mar 3 |
| Richmond Timothy J. | EVP, CHIEF HR OFFICER | Sell | 21,250 | $210.45 | $4.5M | 2025 Mar 3 |
| Siatis Perry C | EVP, GC AND SECRETARY | Sell | 27,900 | $208.69 | $5.8M | 2025 Mar 3 |
| Buckbee Kevin K | SVP, CONTROLLER | Sell | 18,944 | $203.41 | $3.9M | 2025 Feb 26 |
| Richmond Timothy J. | EVP, CHIEF HR OFFICER | Sell | 29,917 | $202.90 | $6.1M | 2025 Feb 26 |
| Siatis Perry C | EVP, GC AND SECRETARY | Sell | 5,778 | $197.90 | $1.1M | 2025 Feb 20 |
| Buckbee Kevin K | SVP, CONTROLLER | Sell | 1,800 | $172.24 | $310,032 | 2024 Dec 16 |
| Gonzalez Richard A | EXECUTIVE CHAIRMAN OF BOARD | Sell | 66,500 | $186.52 | $12.4M | 2024 Aug 5 |
| Gonzalez Richard A | EXECUTIVE CHAIRMAN OF BOARD | Sell | 282,845 | $175.00 | $49.5M | 2024 Jul 17 |
| Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | Sell | 21,082 | $176.30 | $3.7M | 2024 Mar 20 |
| Stewart Jeffrey Ryan | EVP, CHIEF COMMERCIAL OFFICER | Sell | 58,949 | $178.79 | $10.5M | 2024 Mar 18 |
| Richmond Timothy J. | EVP, CHIEF HR OFFICER | Sell | 75,680 | $177.27 | $13.4M | 2024 Mar 1 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $244.60 | 46.0 | $15.9B |
| | $112.44 | 58.9 | $195.8B |
| | $27.96 | 64.8 | $159.3B |
| | $794.08 | 58.2 | $82.1B |
| | $45.60 | 41.8 | -- |
Take ABBV further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put ABBV in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when AbbVie Inc. next reports.
Set alerts on ABBV
Get notified when AbbVie Inc. hits your price targets or technical conditions are met.
Get Started Free